Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Disseminated histoplasmosis as a first clinical manifestation in a patient with small lymphocytic lymphoma: A case report

Silva N, Calvache N, Arrieta E, Bravo JC, Salazar C, Rosales J, Jaramillo F, Restrepo JG.

Biomedica. 2018 Sep 1;38(3):298-302. doi: 10.7705/biomedica.v38i3.3739.

2.

Sequential rituximab and omalizumab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).

Aguirre-Valencia D, Posso-Osorio I, Bravo JC, Bonilla-Abadía F, Tobón GJ, Cañas CA.

Clin Rheumatol. 2017 Sep;36(9):2159-2162. doi: 10.1007/s10067-017-3780-9. Epub 2017 Jul 31. Review.

PMID:
28762062
3.

Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial.

Mera RM, Bravo LE, Camargo MC, Bravo JC, Delgado AG, Romero-Gallo J, Yepez MC, Realpe JL, Schneider BG, Morgan DR, Peek RM Jr, Correa P, Wilson KT, Piazuelo MB.

Gut. 2018 Jul;67(7):1239-1246. doi: 10.1136/gutjnl-2016-311685. Epub 2017 Jun 24.

4.

Sclerosing Encapsulated Peritonitis: A devastating and infrequent disease complicating kidney transplantation, case report and literature review.

Caicedo L, Delgado A, Caicedo LA, Bravo JC, Thomas LS, Rengifo M, Villegas JI, Serrano O, Echeverri GJ.

Int J Surg Case Rep. 2017;33:135-138. doi: 10.1016/j.ijscr.2017.02.048. Epub 2017 Mar 1.

5.

On-line flow injection molecularly imprinted solid phase extraction for the preconcentration and determination of 1-hydroxypyrene in urine samples.

Serrano M, Bartolomé M, Bravo JC, Paniagua G, Gañan J, Gallego-Picó A, Garcinuño RM.

Talanta. 2017 May 1;166:375-382. doi: 10.1016/j.talanta.2016.01.048. Epub 2016 Jan 25.

PMID:
28213249
6.

Muscle activation and heart rate responses to a side-step interval exercise.

Thiebaud RS, Abe T, Bravo JC, Giovannitti N, Sullivan AP.

Clin Physiol Funct Imaging. 2018 Mar;38(2):285-290. doi: 10.1111/cpf.12413. Epub 2017 Feb 16.

PMID:
28205417
7.

Sinusal reversion of supraventricular tachyarrhythmias after propofol administration. A case series.

Montero-Tinnirello J, Magaldi M, Fontanals J, Masgoret P, Bravo JC.

Med Intensiva. 2017 Nov;41(8):499-501. doi: 10.1016/j.medin.2016.10.002. Epub 2016 Dec 24. English, Spanish. No abstract available.

8.

DNA Methylation Predicts Progression of Human Gastric Lesions.

Schneider BG, Mera R, Piazuelo MB, Bravo JC, Zabaleta J, Delgado AG, Bravo LE, Wilson KT, El-Rifai W, Peek RM Jr, Correa P.

Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1607-13. doi: 10.1158/1055-9965.EPI-15-0388. Epub 2015 Aug 12.

9.

Synthesis of a molecularly imprinted polymer for the isolation of 1-hydroxypyrene in human urine.

Serrano M, Bartolomé M, Gallego-Picó A, Garcinuño RM, Bravo JC, Fernández P.

Talanta. 2015 Oct 1;143:71-76. doi: 10.1016/j.talanta.2015.04.092. Epub 2015 May 8.

PMID:
26078130
10.

[Renal biopsies during the second trimester of pregnancy: report of two cases].

Vukusich A, Valls G, Enberg M, Piedra MJ, Contreras L, Bravo JC.

Rev Med Chil. 2013 Aug;141(8):1072-5. doi: 10.4067/S0034-98872013000800016. Spanish.

11.

Primary angiitis of the central nervous system: a report of three cases from a single colombian center.

Coronel-Restrepo N, Bonilla-Abadía F, Cortes OA, Izquierdo JH, Shinchi AM, Bravo JC, Tobón GJ, Cañas CA.

Case Rep Neurol Med. 2013;2013:940438. doi: 10.1155/2013/940438. Epub 2013 May 8.

12.

Diphenylamine and derivatives as predictors of gunpowder age by means of HPLC and statistical models.

López-López M, Bravo JC, García-Ruiz C, Torre M.

Talanta. 2013 Jan 15;103:214-20. doi: 10.1016/j.talanta.2012.10.035. Epub 2012 Oct 26.

PMID:
23200380
13.

[Association of interleukin-1 genetic polymorphism and CagA positive Helicobacter pylori with gastric cancer in Colombia].

Martínez T, Hernández-Suárez G, Bravo MM, Trujillo E, Quiroga A, Albis R, Robayo JC, Bravo JC, Camorlinga M.

Rev Med Chil. 2011 Oct;139(10):1313-21. doi: /S0034-98872011001000010. Epub 2012 Jan 3. Spanish.

14.

Determination of ethylene glycol dinitrate in dynamites using HPLC: application to the plastic explosive Goma-2 ECO.

Sáiz J, Bravo JC, Velasco Ávila E, Torre M, García-Ruiz C.

J Sep Sci. 2011 Dec;34(23):3353-8. doi: 10.1002/jssc.201100523. Epub 2011 Nov 3.

PMID:
22052789
15.

[Reproducibility of histopathologic diagnosis of precursor lesions of gastric carcinoma in three Latin American countries].

Kasamatsu E, Bravo LE, Bravo JC, Aguirre-García J, Flores-Luna L, Nunes-Velloso Mdel C, Hernández-Suárez G.

Salud Publica Mex. 2010 Sep-Oct;52(5):386-90. Spanish.

PMID:
21031244
16.

[A new case of rhinosporidiosis in Chile].

Brevis P, Morales E, Bravo JC, Monasterio V, Mánques B, Zaror L, Abaca P, Toloza L.

Rev Iberoam Micol. 2010 Oct-Dec;27(4):183-5. doi: 10.1016/j.riam.2010.10.001. Epub 2010 Oct 13. Spanish.

17.

Leg ulcers in the antiphospholipid syndrome may be considered as a form of pyoderma gangrenosum and they respond favorably to treatment with immunosuppression and anticoagulation.

Cañas CA, Durán CE, Bravo JC, Castaño DE, Tobón GJ.

Rheumatol Int. 2010 Jul;30(9):1253-7. doi: 10.1007/s00296-010-1418-1. Epub 2010 Mar 28.

PMID:
20349240
18.

A new method for total mercury and methyl mercury analysis in muscle of seawater fish.

Carbonell G, Bravo JC, Fernández C, Tarazona JV.

Bull Environ Contam Toxicol. 2009 Aug;83(2):210-3. doi: 10.1007/s00128-009-9720-x. Epub 2009 Apr 17.

PMID:
19373425
19.

A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country.

Fischbach LA, Bravo LE, Zarama GR, Bravo JC, Ojha RP, Priest EL, Collazos T, Casabon AL, Guerrero LZ, Singh KP, Correa P.

Helicobacter. 2009 Apr;14(2):100-8. doi: 10.1111/j.1523-5378.2009.00667.x. Erratum in: Helicobacter. 2009 Aug;14(4):309. Ojha, Priyadarshi Rohit [corrected to Ojha, Rohit Priyadarshi]; Casabon, Lucy Alba [corrected to Casabon, Alba Lucy]; Singh, P Karan [corrected to Singh, Karan P].

PMID:
19298337
20.

Selective solid-phase extraction of ethynylestradiol from river water by molecularly imprinted polymer microcolumns.

Bravo JC, Garcinuño RM, Fernández P, Durand JS.

Anal Bioanal Chem. 2009 Mar;393(6-7):1763-8. doi: 10.1007/s00216-008-2563-1. Epub 2008 Dec 20.

PMID:
19099238
21.

Effect of smoking on failure of H. pylori therapy and gastric histology in a high gastric cancer risk area of Colombia.

Camargo MC, Piazuelo MB, Mera RM, Fontham ET, Delgado AG, Yepez MC, Ceron C, Bravo LE, Bravo JC, Correa P.

Acta Gastroenterol Latinoam. 2007 Dec;37(4):238-45.

22.

[Source of variation in the diagnosis of Helicobacter pylori-associated multifocal atrophic gastritis.]

Bravo LE, Bravo JC, Realpe JL, Zarama G, Piazuelo MB, Correa P.

Colomb Med (Cali). 2008 Jan;39(1):58-65. Spanish.

23.

Linear IgA bullous dermatosis associated with systemic lupus erythematosus: a case report.

Tobón GJ, Toro CE, Bravo JC, Cañas CA.

Clin Rheumatol. 2008 Mar;27(3):391-3. Epub 2007 Oct 12.

PMID:
17932615
24.

A new molecularly imprinted polymer for the on-column solid-phase extraction of diethylstilbestrol from aqueous samples.

Bravo JC, Garcinuño RM, Fernández P, Durand JS.

Anal Bioanal Chem. 2007 Jul;388(5-6):1039-45. Epub 2007 Mar 13.

PMID:
17431595
25.

Re: long term follow up of patients treated for Helicobacter pylori infection.

Mera R, Fontham ET, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC, Correa P.

Gut. 2007 Mar;56(3):436. No abstract available.

26.

Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population.

Plummer M, Vivas J, Lopez G, Bravo JC, Peraza S, Carillo E, Cano E, Castro D, Andrade O, Sánchez V, Garcia R, Buiatti E, Aebischer C, Franceschi S, Oliver W, Muñoz N.

J Natl Cancer Inst. 2007 Jan 17;99(2):137-46.

PMID:
17227997
27.

Re: Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.

Mera R, Fontham ET, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC, Correa P.

J Natl Cancer Inst. 2006 Oct 4;98(19):1426. No abstract available.

PMID:
17018791
28.

Duration of exposure, a neglected factor in chemoprevention trials.

Fontham ET, Correa P, Mera R, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC.

Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2465-6. No abstract available.

29.

Flow injection fluorimetric determination of beta-estradiol using a molecularly imprinted polymer.

Bravo JC, Fernández P, Durand JS.

Analyst. 2005 Oct;130(10):1404-9. Epub 2005 Aug 31.

PMID:
16172666
30.

Long term follow up of patients treated for Helicobacter pylori infection.

Mera R, Fontham ET, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC, Correa P.

Gut. 2005 Nov;54(11):1536-40. Epub 2005 Jun 28.

31.

Infrequency of microsatellite instability in complete and incomplete gastric intestinal metaplasia.

Garay J, Bravo JC, Correa P, Schneider BG.

Hum Pathol. 2004 Jan;35(1):102-6.

PMID:
14745731
32.

Epstein-Barr virus-associated gastric carcinoma in Cali, Colombia.

Carrascal E, Koriyama C, Akiba S, Tamayo O, Itoh T, Eizuru Y, Garcia F, Sera M, Carrasquilla G, Piazuelo MB, Florez L, Bravo JC.

Oncol Rep. 2003 Jul-Aug;10(4):1059-62.

PMID:
12792770
33.

Regions of allelic imbalance in the distal portion of chromosome 12q in gastric cancer.

Schneider BG, Rha SY, Chung HC, Bravo JC, Mera R, Torres JC, Plaisance KT Jr, Schlegel R, McBride CM, Reveles XT, Leach RJ.

Mol Pathol. 2003 Jun;56(3):141-9.

34.

Histopathology of gastritis in Helicobacter pylori-infected children from populations at high and low gastric cancer risk.

Bedoya A, Garay J, Sanzón F, Bravo LE, Bravo JC, Correa H, Craver R, Fontham E, Du JX, Correa P.

Hum Pathol. 2003 Mar;34(3):206-13.

PMID:
12673553
35.

CDKN2A promoter methylation in gastric adenocarcinomas: clinical variables.

Vo QN, Geradts J, Boudreau DA, Bravo JC, Schneider BG.

Hum Pathol. 2002 Dec;33(12):1200-4.

PMID:
12514789
36.

Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation.

Vo QN, Geradts J, Gulley ML, Boudreau DA, Bravo JC, Schneider BG.

J Clin Pathol. 2002 Sep;55(9):669-75.

37.

Morphometric evaluation of gastric antral atrophy: improvement after cure of Helicobacter pylori infection.

Ruiz B, Garay J, Correa P, Fontham ET, Bravo JC, Bravo LE, Realpe JL, Mera R.

Am J Gastroenterol. 2001 Dec;96(12):3281-7.

PMID:
11774937
38.

Anti-inflammatory and tissue-protectant drug effects: results from a randomized placebo-controlled trial of gastritis patients at high risk for gastric cancer.

Fischbach LA, Correa P, Ramirez H, Realpe JL, Collazos T, Ruiz B, Bravo LE, Bravo JC, Casabon AL, Schmidt BA.

Aliment Pharmacol Ther. 2001 Jun;15(6):831-41.

39.

Helicobacter pylori genotypes may determine gastric histopathology.

Nogueira C, Figueiredo C, Carneiro F, Gomes AT, Barreira R, Figueira P, Salgado C, Belo L, Peixoto A, Bravo JC, Bravo LE, Realpe JL, Plaisier AP, Quint WG, Ruiz B, Correa P, van Doorn LJ.

Am J Pathol. 2001 Feb;158(2):647-54.

40.

Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.

Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, Realpe JL, Malcom GT, Li D, Johnson WD, Mera R.

J Natl Cancer Inst. 2000 Dec 6;92(23):1881-8.

PMID:
11106679
41.

Microsatellite instability, prognosis and metastasis in gastric cancers from a low-risk population.

Schneider BG, Bravo JC, Roa JC, Roa I, Kim MC, Lee KM, Plaisance KT Jr, McBride CM, Mera R.

Int J Cancer. 2000 Sep 20;89(5):444-52.

42.

Unsuccessful treatment results in survival of less virulent genotypes of Helicobacter pylori in Colombian patients.

Correa P, van Doorn LJ, Bravo JC, Ruiz B, Bravo LE, Realpe JL.

Am J Gastroenterol. 2000 Feb;95(2):564-6. No abstract available.

PMID:
10685783
43.
44.
45.

KRAS mutations predict progression of preneoplastic gastric lesions.

Gong C, Mera R, Bravo JC, Ruiz B, Diaz-Escamilla R, Fontham ET, Correa P, Hunt JD.

Cancer Epidemiol Biomarkers Prev. 1999 Feb;8(2):167-71.

46.

Precancerous lesions in two counties of China with contrasting gastric cancer risk.

You WC, Zhang L, Gail MH, Li JY, Chang YS, Blot WJ, Zhao CL, Liu WD, Li HQ, Ma JL, Hu YR, Bravo JC, Correa P, Xu GW, Fraumeni JF Jr.

Int J Epidemiol. 1998 Dec;27(6):945-8.

PMID:
10024186
47.

Helicobacter pylori infection, garlic intake and precancerous lesions in a Chinese population at low risk of gastric cancer.

You WC, Zhang L, Gail MH, Ma JL, Chang YS, Blot WJ, Li JY, Zhao CL, Liu WD, Li HQ, Hu YR, Bravo JC, Correa P, Xu GW, Fraumeni JF Jr.

Int J Epidemiol. 1998 Dec;27(6):941-4.

PMID:
10024185
48.

Recombinant oncotoxin AR209 (anti-P185erbB-2) diminishes human prostate carcinoma xenografts.

Skrepnik N, Zieske AW, Bravo JC, Gillespie AT, Hunt JD.

J Urol. 1999 Mar;161(3):984-9.

PMID:
10022738
49.

Aggressive administration of recombinant oncotoxin AR209 (anti-ErbB-2) in athymic nude mice implanted with orthotopic human non-small cell lung tumours.

Skrepnik N, Zieske AW, Robert E, Bravo JC, Mera R, Hunt JD.

Eur J Cancer. 1998 Sep;34(10):1628-33.

PMID:
9893641
50.

Review article: Antioxidant micronutrients and gastric cancer.

Correa P, Malcom G, Schmidt B, Fontham E, Ruiz B, Bravo JC, Bravo LE, Zarama G, Realpe JL.

Aliment Pharmacol Ther. 1998 Feb;12 Suppl 1:73-82. Review.

Supplemental Content

Loading ...
Support Center